Interleukin-10 in Non-Hodgkin's Lymphoma

References

• Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by the Th1 clones. J. Exp. Med. 1989; 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Vieira P., Waal-Malefyt R., Dan M.-N., Johnson K.E., Kastelein R., Fiorentino D.F., de Vries J.E., Roncarolo M-C., Mosmann T.R., Moore K.W. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA 1991; 88: 1172–1176
   PubMed Web of Science ®Google Scholar
• Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., Mosmann T.R. Homology of cytokinc synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990; 248: 1230–1234
   PubMed Web of Science ®Google Scholar
• Moore K.W., Rousset F., Banchereau J. Evolving principles in immunopathology: Interleukin 10 and its relationship to Epstein Barr virus protein BCRF1. Spinger Semin. Immunopathology. 1991; 13: 157–166
   PubMed Web of Science ®Google Scholar
• Kim J.M., Brannan C.I., Copeland N.G., Jenkins N.A., Khan T.A., Moore K.W. Structure of the mouse interleukin 10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 1992; 148: 3618–3623
   PubMed Web of Science ®Google Scholar
• Kuhe D., Platzer C., von Knethen A., Straub H., Bohlen H., Hafner M., Teach H. Isolation of the human interleukin 10 promoter. Characterization of the promoter. activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1–7
   PubMed Web of Science ®Google Scholar
• Yssel H., de Waal Malefyt R., Roncardlo M.G., Abrams J.S., Lahesman R., Spits H., de Vries J. Interleukin 10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cell. J. immunol.
   Google Scholar
• Benjamin D., Knobloch T.J., Dayton M.A. Human B-cell interleukin 10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin 10. Blood 1992; 80: 1289–1298
   PubMed Web of Science ®Google Scholar
• O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., Barbis D., Stall A., Cupp J., Moore K., Vieira P., Mosmann T., Whitmore A., Arnold L., Haughton G., Howard M. Production of cytokines hy mouse B cells: iymphomas and normal B cells produce interleukin 10. Int. Immunol. 1990; 2: 821–832
   PubMed Web of Science ®Google Scholar
• O'Garra A., Chang R., Hastings R., Go N., Haughton G., Howard M. Lyl B (B-1) cells are the main source of B-cell derived IL-10. Eur. J. Immunol. 1992; 22: 711–717
   PubMed Web of Science ®Google Scholar
• Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cell. J. Immunol. 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• De Waal-Malefyt R., Haanen J., Spits H., Roncarolo M.C., te Velde A., Figdar C., Johnson K., Kastelein R., Yasel H., de Vries J.E. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II MHC expression. J. Exp. Med. 1991; 174: 915–924
   PubMed Web of Science ®Google Scholar
• Hsu D.H., Moore K.W., Spits H. Differential effects of interleukin-4 and -10 and interleukin-2-induced interferon-γ synthesis and lymphokine-activited killer activity. Int. Immunol 1992; 4: 563–569
   PubMed Web of Science ®Google Scholar
• De Waal-Malefyt K., Abrams J., Bennett B., Figdar C., de Vries J. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991; 174: 1209–1220
   PubMed Web of Science ®Google Scholar
• Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991; 174: 1549–1555
   PubMed Web of Science ®Google Scholar
• Taga K., Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J. Immunol. 1992; 148: 1143–1148
   PubMed Web of Science ®Google Scholar
• MacNeil I., Suda T., Moore K.W., Mosman T.R., Zlotnik A. IL-10: a novel cytokine growth cofactor for mature and immature T cells. J. Immunol. 1990; 145: 4167–4173
   PubMed Web of Science ®Google Scholar
• Chen W.-F., Zlotnik A. Interleukin 10: A novel cytotoxic T cell differentiation factor. J. Immunol. 1991; 147: 528–534
   PubMed Web of Science ®Google Scholar
• Go N.F., Castle B.E., Barrett R., Kastelein K., Dang W., Mosmann T.R., Moore K.W., Howard M. Interleukin 10 (IL-10), a novel B cell stimulatory factor: unresponsiveness of X chromosome linked immunodeficiency B cells. J. Exp. Med. 1990; 172: 1625–1631
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Defrance T., Peronne C., Hsu D.-H., Kastelein R., Moore K.W., Banchereau J. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 1992; 89: 1890–1893
   PubMed Web of Science ®Google Scholar
• Thompson-Snipes L., Dhar V., Bond M.W., Mosmann T.R., Moore K.W., Rennick D. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J. Exp Med. 1991; 173: 507–510
   PubMed Web of Science ®Google Scholar
• Defrance T., Vandervliet B., Briere F., Durand I., Rousset F., Benchereau J. Interleukin 10 and transforming factor b cooperate to induce anti-CD40-activated naive human B cells lo secrete immunoglobulin A. J. Exp. Med. 1992; 175: 671–682
   PubMed Web of Science ®Google Scholar
• Hsu D.H., de Waal-Malefyt R., Fiorentino D.F., Dang M.N., Vieira P., de Vries J., Spits H., Mosmann T.R., Moore K.W. Expression of IL-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830–832
   PubMed Web of Science ®Google Scholar
• Hudson G.S., Bankier A.T., Satchwell S.C., Barrell B.G. The short unique region of the B45–8 Epstein-Barr-virus genome. Virology 1985; 147: 81–98
   PubMed Web of Science ®Google Scholar
• Finke J., Ternes P., Lange W., Mertelsmann K., Dölken G. Expression of interleukin 10 in B lymphocytes of different origin. Leukemia 1993; 7: 1852–1857
   PubMed Web of Science ®Google Scholar
• Burdin N., Péronne C., Banchereau J., Rousset F. Epstein Harr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 1993; 177: 295–304
   PubMed Web of Science ®Google Scholar
• Emilie D., Touitou R., Raphael M., Peuchmaur M., Devergnee O., Rea D., Coumbraras J., Crevan M.C., Edelman L., Joab I., Galanaud P. In vivo production of interleukin-10 by malignant cells in AIDS lymphoma. Eur. J. Immunol. 1992; 22: 2937–2942
   PubMed Web of Science ®Google Scholar
• Masood R., Zhang Y., Band M.W., Scadden D.T., Moudgil T., Law R.E., Kaplan M.H., Jung N.B., Espina B.M., Lunardi-Iskandar Y., Levine A.M., Gill P.S. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995; 85: 3423–3430
   PubMed Web of Science ®Google Scholar
• Barocchi R.A., Rosa M.E., Tan J.C., Chou C.-C., Sullivan M.A. Lymphomagenesis in the SCID-hu mouse involves production of human interleukin-10. Blood 1995; 85: 1063–1074
   PubMed Web of Science ®Google Scholar
• Blay J-Y., Burdin N., Rousset F., Lenoir G., Biron P., Philip T., Banchereau J., Favrot M.C. Serum interleukin-10 in Non-Hodgkin's lymphoma: a prognostic factor. Blood 1993; 82: 2169–2174
   PubMed Web of Science ®Google Scholar
• Stasi R., Zinzani P.L., Galieni P., Lauta V.M., Damasio E., Dispensa E., Dammacco F., Tura S., Papa G. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Cancer 1994; 74: 1792–1800
   PubMed Web of Science ®Google Scholar
• Stasi R., Zinzani P.L., Galieni P., Lauta V.M., Damasio E., Dispensa E., Dammacco F., Papa G., Tura S. Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma. Br. J. Hematol. 1994; 88: 770–777
   PubMed Web of Science ®Google Scholar
• Cortes J.E., Talpaz M., Cabanillas F., Seymour J.F., Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis. Blood 1995; 85: 2516–2520
   PubMed Web of Science ®Google Scholar
• Blay J-Y., Voorzanger N., Favrot M., Burdin N., Rousset F., Banchereau J. Presence of Epstein-Barr virus viral interleukin-10 in the serum of patients with non-human immunodeficiency virus-related diffuse large-cell non-Hodgkin's lymphomas (Letter). Blood 1995; 86: 4702–4707
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Jiwa M., van der Valk P., Walboomers J., Horstman A., Meijer C. J. L. M. Expression of Epstein Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt immunodeficiency. Humam Pathol. 1993; 24: 725
   PubMed Web of Science ®Google Scholar